Search
Search Results
-
Lipoprotein(a): what clinicians need to know
534PDF: 930HTML: 30 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
2105PDF: 2833Supplementary: 350Appendix: 281 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
863PDF: 248Supplementary: 155Appendix: 119HTML: 64 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
246PDF: 267Supplementary: 158HTML: 31 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
848PDF: 220Supplementary: 161Appendix: 116HTML: 44 -
Coronary artery calcium scoring. What clinicians need to know
1194PDF: 274HTML: 137 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1351PDF: 668Appendix: 251HTML: 31 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1233pdf: 280Supplementary Material: 47HTML: 145 -
Epidemiology of peripartum cardiomyopathy in Africa
2421PDF: 534HTML: 119 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3660PDF: 594Appendix: 421HTML: 32 -
Dyslipidemia and stroke-related mortality in the United States: a nationwide analysis for 2010-2020
276PDF: 78Supplementary: 20HTML: 21 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
301PDF: 122Supplementary: 32HTML: 15 -
Modulation of cardiac metabolism in heart failure
2431PDF: 1182HTML: 54 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
2082PDF: 557SUPPLEMENTARY MATERIAL: 312GRAPHICAL ABSTRACT: 277HTML: 40

